This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: South Florida Medical Research
South Florida Medical Research is seeking participants for a study on new medications and treatments targeting advanced prostate cancer that has spread from the prostate gland to the lymph nodes, bones or other organs of the body.
AVENTURA, Florida, (PRWEB) January 02, 2013
January 2, 2013 – South Florida Medical Research is seeking participants for a study on new medications and treatments targeting advanced prostate cancer that has spread from the prostate gland to the lymph nodes, bones or other organs of the body.
Men who have been diagnosed with advanced prostate cancer may be experiencing symptoms that include severe back pain, bone fractures, spinal cord compression, high calcium levels and a decreasing quality of life. Symptoms vary according to the extent of bone involvement and the aggressiveness of the cancer.
Advanced prostate cancer is often difficult to cure, but with effective treatment patients improvement of symptoms or prolong survival for several years.
Most new cancer treatments are developed in clinical trials like those performed by the physicians and staff of South Florida Medical Research. These studies are designed to answer specific questions about new and developing treatments, or new ways of using known treatments. Prescription medications provided to patient volunteers have gone through the clinical trial process and are FDA approved for use. Thanks to these clinical trials and research studies, study participants receive access to expert medical treatment during the trial at no cost, and are educated about their illness – a crucial element for participants to achieve successful results.
South Florida Medical Research medical experts evaluate the effectiveness of new drugs or treatment strategies with advanced prostate cancer patients. Participation in a clinical trial may offer access to better treatments and advance the existing knowledge about treatment of this cancer.
There are various treatments in place for advanced prostate cancer, including chemotherapy, hormone therapy, radiation therapy and surgery. The investigational medication used in this program is intended to treat cancers which respond to hormones. All study-related medications and care are provided to the volunteer patients at no cost and participants need no insurance.
To learn more about this program and to see if you may qualify to participate, contact South Florida Medical Research at Info@southfloridamedicalresearch.com or see the enrollment tab on this site.
Specific medical requirements must be met for inclusion into this and all clinical studies.
To learn more about this clinical trial and find out if you are eligible to participate, please contact South Florida Medical Research by calling 305-931-8080, or Email firstname.lastname@example.org.
About South Florida Medical Research:
For more than 20 years, South Florida Medical Research has been dedicated to the development of future medical treatments and therapies. Through clinical trials and research, it is possible to develop newer, more innovative therapies for a wide range of medical issues.
Through its clinical trial programs, South Florida Medical Research serves the medical community by contributing to the understanding of diseases which affect many lives. The broad range of medical research conducted by South Florida Medical Research incorporates the fields of urology, sexual health, obstetrics/gynecology, cardiology, neurology, psychiatry, internal medicine, family medicine, cancer research and more.
South Florida Medical Research Executive Director Marc C. Gittelman, M.D., F.A.C.S., is a Board-certified urologist, in practice since 1988. Dr. Gittleman has overseen more than 350 clinical research trials since 1992. SFMR physician staff includes six urologists, two gynecologists, a cardiologist/internal medicine specialist, a rheumatologist, two neurologists and a family medicine practitioner. This private, research-specific facility has 16 full-time trained research staff members dedicated to conducting clinical trials. A strong patient recruitment department and clinical and data quality assurance staff ensures SFMR processes are accurate and complete.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10283536.htm